Raymond J. Henley Iii

Array ( [id] => 556859 [patent_doc_number] => 07468394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-23 [patent_title] => 'Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation' [patent_app_type] => utility [patent_app_number] => 10/384679 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3947 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468394.pdf [firstpage_image] =>[orig_patent_app_number] => 10384679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545267 [patent_doc_number] => 07163960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Treatment and prevention of inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 10/384369 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 11736 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163960.pdf [firstpage_image] =>[orig_patent_app_number] => 10384369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691129 [patent_doc_number] => 07074825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Composition and method for treating cancer' [patent_app_type] => utility [patent_app_number] => 10/383811 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7658 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074825.pdf [firstpage_image] =>[orig_patent_app_number] => 10383811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779290 [patent_doc_number] => 06995158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => 'Pharmaceutical preparation containing at least folic acid or a folate and tetrahydrobiopterin (BH4) or derivatives thereof used for the treating or preventing cardiovascular or neurological disorders by modulation of the activity of nitric oxide synthase (NOS)' [patent_app_type] => utility [patent_app_number] => 10/377618 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6536 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995158.pdf [firstpage_image] =>[orig_patent_app_number] => 10377618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990783 [patent_doc_number] => 06919310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Method of treating the syndrome of coronary heart disease risk factors in humans' [patent_app_type] => utility [patent_app_number] => 10/377838 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6132 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919310.pdf [firstpage_image] =>[orig_patent_app_number] => 10377838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596167 [patent_doc_number] => 07981899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Use of compatible solutes for inhibiting the release of ceramides' [patent_app_type] => utility [patent_app_number] => 10/509368 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9234 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981899.pdf [firstpage_image] =>[orig_patent_app_number] => 10509368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151012 [patent_doc_number] => 20040171591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Method for decreasing low density lipoprotein' [patent_app_type] => new [patent_app_number] => 10/377088 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4096 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171591.pdf [firstpage_image] =>[orig_patent_app_number] => 10377088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153097 [patent_doc_number] => 06767905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-27 [patent_title] => 'Use of angiotensin II receptor antagonists for treating acute myocardial infarction' [patent_app_type] => B2 [patent_app_number] => 10/376049 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4960 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767905.pdf [firstpage_image] =>[orig_patent_app_number] => 10376049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068830 [patent_doc_number] => 06844356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Hemorrhoid therapeutic treatment' [patent_app_type] => utility [patent_app_number] => 10/374377 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2474 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844356.pdf [firstpage_image] =>[orig_patent_app_number] => 10374377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387763 [patent_doc_number] => 20040029954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease' [patent_app_type] => new [patent_app_number] => 10/372510 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14575 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029954.pdf [firstpage_image] =>[orig_patent_app_number] => 10372510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020249 [patent_doc_number] => 20050222268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Remedy for hypertension' [patent_app_type] => utility [patent_app_number] => 10/504585 [patent_app_country] => US [patent_app_date] => 2003-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3174 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222268.pdf [firstpage_image] =>[orig_patent_app_number] => 10504585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867522 [patent_doc_number] => 07364757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Methods of treating vascular disease' [patent_app_type] => utility [patent_app_number] => 10/367277 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 58 [patent_no_of_words] => 16562 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364757.pdf [firstpage_image] =>[orig_patent_app_number] => 10367277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729731 [patent_doc_number] => 20030185921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'COMPOUNDS AND COMPOSITIONS DERIVED FROM OLIVES AND METHODS OF USE THEREOF' [patent_app_type] => new [patent_app_number] => 10/364305 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3419 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185921.pdf [firstpage_image] =>[orig_patent_app_number] => 10364305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7257223 [patent_doc_number] => 20050143467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Stimulation of cpt-1 as a means to reduce weight' [patent_app_type] => utility [patent_app_number] => 10/503605 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4615 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143467.pdf [firstpage_image] =>[orig_patent_app_number] => 10503605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1128121 [patent_doc_number] => RE038576 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Stabilized aspirin compositions and method of preparation for oral and topical use' [patent_app_type] => E1 [patent_app_number] => 10/359693 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038576.pdf [firstpage_image] =>[orig_patent_app_number] => 10359693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 724806 [patent_doc_number] => 07045534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Methods of reducing angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/358370 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7962 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045534.pdf [firstpage_image] =>[orig_patent_app_number] => 10358370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225301 [patent_doc_number] => 20050255096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Combination treatment for acute myocardial infarction' [patent_app_type] => utility [patent_app_number] => 10/502981 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3062 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255096.pdf [firstpage_image] =>[orig_patent_app_number] => 10502981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711666 [patent_doc_number] => 20030171415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors' [patent_app_type] => new [patent_app_number] => 10/354713 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3942 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171415.pdf [firstpage_image] =>[orig_patent_app_number] => 10354713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968599 [patent_doc_number] => 06939873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Non-sedating barbituric acid derivatives' [patent_app_type] => utility [patent_app_number] => 10/354146 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10915 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939873.pdf [firstpage_image] =>[orig_patent_app_number] => 10354146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706855 [patent_doc_number] => 20030153589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Non-sedating barbiturate compounds as neuroprotective agents' [patent_app_type] => new [patent_app_number] => 10/333957 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5807 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153589.pdf [firstpage_image] =>[orig_patent_app_number] => 10333957 [rel_patent_id] =>[rel_patent_doc_number] =>)